Article | April 11, 2024

Nucleic Acid Therapeutics And Environmental Impact

Source: Cytiva

By Tracy Humphries, Cytiva Marketing Leader, Nucleic Acid Therapeutics

Nucleic acid therapeutics are emerging as a pivotal part of the next generation of therapies. Modalities like viral vectors, RNA forms, plasmids, CAR-T, and cell therapies are becoming more prominent in the early stages of therapeutic development. Nucleic acid therapeutics, based on RNA or DNA, are opening up exciting new avenues of treatment for researchers. These therapies can be tailored to silence, express, and modify specific genes, offering a flexible and powerful approach to disease prevention and treatment. Continue reading to learn about the history of nucleic acid therapeutics as well as the environmental impact of manufacturing mRNA and oligonucleotides for therapeutics.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online